Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action [J]. Experimental Cell Research, 2006, 312(5) :594-607.
[3]
赵锐 顾谦群.海洋活性肽的研究进展[J].海洋科学,:.
[4]
Aneiros A, Garateix A. Bioactive peptides from marine sources:pharmacological properties and isolation procedures [J]. Journal of Chromatography, 2004, 803 (1) :41-53.
[5]
Minuzzo M, Ceribelli M. Selective effects of the anti- cancer drug Yondelis (ET-743) on cell-cycle promoters [J]. Molecular Pharmacology, 2005, 68(5): 1 496- 1 503.
[6]
Paramvir D, Yutaka S, Robert K, et al. Campbell the draft genome of ciona intestinalis:insights into chordate and vertebrate origins [J]. Science, 2002, 298(5 601) :2 157-2 167.
[7]
Westerfield M. The zebrafish book: A guide for the laboratory use of zebrafish (Danio rerio) [M]. 4th ed. Eugene: University of Oregon Press, 2000.
[8]
Serbedzija G N, Flynn E, Willett C E. Zebrafish angiogenesis: a new model for drug screening [J]. Angiogenesis,1999,3(4) :353-359.
[9]
Parng C, Seng W L, Semino C, et al. Zebrafish: a preclinical model for drug screening [J]. Assay and Drug Development Technologies, 2002,1 (1) : 41-48.
[10]
Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease [J]. Nat Med, 1995,1 ( 1 ) : 27- 31.
